trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide

C44H56ClN5O8S2 — CID 58289629

IUPACtrans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide
SMILESC=C[C@@H]1C[C@]1(CC(=O)[C@@H]1C[C@@H](Oc2cc(-c3nc(C(C)C)cs3)nc3c(Cl)c(OCCN4CCOCC4)ccc23)[C@H]2CC[C@H]([C@@H](C)CC)C(=O)N21)C(=O)NS(=O)(=O)C1CC1
InChIInChI=1S/C44H56ClN5O8S2/c1-6-26(5)29-10-12-33-38(21-34(50(33)42(29)52)35(51)23-44(22-27(44)7-2)43(53)48-60(54,55)28-8-9-28)58-37-20-31(41-47-32(24-59-41)25(3)4)46-40-30(37)11-13-36(39(40)45)57-19-16-49-14-17-56-18-15-49/h7,11,13,20,24-29,33-34,38H,2,6,8-10,12,14-19,21-23H2,1,3-5H3,(H,48,53)/t26-,27+,29+,33+,34-,38+,44+/m0/s1
InChIKeyHJJBGPWFFTTZEO-DSMRLTDISA-N
MW882.55 g/mol
LogP6.78
Rot. Bonds17

About trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide

trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide (PubChem CID 58289629) has the molecular formula C44H56ClN5O8S2 and a molecular weight of 882.55 g/mol. Its IUPAC name is trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide.

Molecular Properties

Compound Nametrans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide
PubChem CID58289629
Molecular FormulaC44H56ClN5O8S2
Molecular Weight882.55 g/mol
Exact Mass881.33
IUPAC Nametrans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide
SMILESC=C[C@@H]1C[C@]1(CC(=O)[C@@H]1C[C@@H](Oc2cc(-c3nc(C(C)C)cs3)nc3c(Cl)c(OCCN4CCOCC4)ccc23)[C@H]2CC[C@H]([C@@H](C)CC)C(=O)N21)C(=O)NS(=O)(=O)C1CC1
InChIInChI=1S/C44H56ClN5O8S2/c1-6-26(5)29-10-12-33-38(21-34(50(33)42(29)52)35(51)23-44(22-27(44)7-2)43(53)48-60(54,55)28-8-9-28)58-37-20-31(41-47-32(24-59-41)25(3)4)46-40-30(37)11-13-36(39(40)45)57-19-16-49-14-17-56-18-15-49/h7,11,13,20,24-29,33-34,38H,2,6,8-10,12,14-19,21-23H2,1,3-5H3,(H,48,53)/t26-,27+,29+,33+,34-,38+,44+/m0/s1
InChIKeyHJJBGPWFFTTZEO-DSMRLTDISA-N
XLogP6.78
TPSA157.33 Ų
H-Bond Donors1
H-Bond Acceptors12
Rotatable Bonds17
Heavy Atoms60
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500882.55
LogP ≤ 56.78
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide?
The IUPAC name of trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide (CID 58289629) is trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide.
What is the SMILES notation for trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide?
The canonical SMILES for trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide is C=C[C@@H]1C[C@]1(CC(=O)[C@@H]1C[C@@H](Oc2cc(-c3nc(C(C)C)cs3)nc3c(Cl)c(OCCN4CCOCC4)ccc23)[C@H]2CC[C@H]([C@@H](C)CC)C(=O)N21)C(=O)NS(=O)(=O)C1CC1.
What is the InChIKey of trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide?
The InChIKey is HJJBGPWFFTTZEO-DSMRLTDISA-N. The full InChI is InChI=1S/C44H56ClN5O8S2/c1-6-26(5)29-10-12-33-38(21-34(50(33)42(29)52)35(51)23-44(22-27(44)7-2)43(53)48-60(54,55)28-8-9-28)58-37-20-31(41-47-32(24-59-41)25(3)4)46-40-30(37)11-13-36(39(40)45)57-19-16-49-14-17-56-18-15-49/h7,11,13,20,24-29,33-34,38H,2,6,8-10,12,14-19,21-23H2,1,3-5H3,(H,48,53)/t26-,27+,29+,33+,34-,38+,44+/m0/s1.
What are the key properties of trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide?
trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide has a molecular weight of 882.55 g/mol, XLogP of 6.78, 17 rotatable bonds, 1 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for trans-(1R,2S)-1-[2-[(1R,3S,6R,8aR)-6-[(2S)-butan-2-yl]-1-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-2-oxoethyl]-N-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide is sourced from PubChem (CID 58289629), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).